To be effective, cancer detection needs to be simple, readily available, and affordable.
We develop innovative products that quickly and reliably identify the early onset of several leading deadly conditions – such as colorectal (“CRC”) and pancreatic cancer.
Our goal is to place effective solutions where they need to be… In your hands.
Mainz BioMed (NASDAQ: MYNZ) – was founded in Germany and is becoming a leading global provider of easy-to-use diagnostic solutions for patients and healthcare providers everywhere.
If you would like to be kept up to date with the very latest news, please enter your details in the form and we will keep you updated.